ATE367830T1 - Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten - Google Patents

Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten

Info

Publication number
ATE367830T1
ATE367830T1 AT96923791T AT96923791T ATE367830T1 AT E367830 T1 ATE367830 T1 AT E367830T1 AT 96923791 T AT96923791 T AT 96923791T AT 96923791 T AT96923791 T AT 96923791T AT E367830 T1 ATE367830 T1 AT E367830T1
Authority
AT
Austria
Prior art keywords
inactivation
blood products
viral contaminations
contaminations
viral
Prior art date
Application number
AT96923791T
Other languages
English (en)
Inventor
Ruth Laub
Wael Luc De
Giambattista Mario Di
Original Assignee
Caf Dcf Cvba Scrl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/BE1995/000069 external-priority patent/WO1996002571A1/fr
Application filed by Caf Dcf Cvba Scrl filed Critical Caf Dcf Cvba Scrl
Application granted granted Critical
Publication of ATE367830T1 publication Critical patent/ATE367830T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3623—Means for actively controlling temperature of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • External Artificial Organs (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96923791T 1995-07-14 1996-07-15 Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten ATE367830T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BE1995/000069 WO1996002571A1 (fr) 1994-07-14 1995-07-14 Concentre de fibrinogene issu de plasma sanguin, procede et installation pour sa preparation

Publications (1)

Publication Number Publication Date
ATE367830T1 true ATE367830T1 (de) 2007-08-15

Family

ID=3888743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96923791T ATE367830T1 (de) 1995-07-14 1996-07-15 Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten

Country Status (9)

Country Link
US (2) US6190608B1 (de)
EP (2) EP0840624B1 (de)
JP (2) JPH11509210A (de)
AT (1) ATE367830T1 (de)
CA (1) CA2225470C (de)
DE (3) DE69637181T2 (de)
DK (1) DK0840624T3 (de)
ES (1) ES2290957T3 (de)
WO (1) WO1997003706A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE367830T1 (de) * 1995-07-14 2007-08-15 Caf Dcf Cvba Scrl Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten
GB9821342D0 (en) 1998-10-02 1998-11-25 Common Services Agency Device for treatment of biological fluids
US6970740B2 (en) * 2000-04-19 2005-11-29 Clemson University UVC rediation therapy for leukemia
WO2001080939A2 (en) 2000-04-19 2001-11-01 Clemson University Uvc radiation therapy for chronic lymphocytic leukemia
DE10031851B4 (de) * 2000-07-04 2005-10-13 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Photodynamische Behandlung und UV-B-Bestrahlung einer Thrombozyten-Suspension
DE10056096A1 (de) 2000-11-13 2002-06-13 Bayer Ag Vorrichtung zur Bestrahlung von Flüssigkeiten
US7381976B2 (en) * 2001-03-13 2008-06-03 Triton Thalassic Technologies, Inc. Monochromatic fluid treatment systems
US20030030011A1 (en) * 2001-05-17 2003-02-13 Purepulse Technologies, Inc. Light treatment control in a fluid treatment system using light for the treatment of fluid products
US20030060747A1 (en) * 2001-05-17 2003-03-27 Fries William M. Fluid flow path for a fluid treatment system using light for the decontamination of fluid products
DE10152159A1 (de) * 2001-10-25 2003-05-15 Aventis Behring Gmbh Verfahren zur proteinschonenden Reinigung von kontaminierten biologischen Flüssigkeiten
MXPA04010027A (es) * 2002-04-12 2005-07-01 Throwleigh Technologies L L C Metodos y aparatos para descontaminar fluidos.
AU2003259514A1 (en) * 2002-08-30 2004-03-19 Globalmed Technologies De Colombia S.A. Apparatus and method for treating infectious diseases
CN100522989C (zh) 2002-09-11 2009-08-05 中外制药株式会社 纯化蛋白质的方法
EP1400248A1 (de) * 2002-09-19 2004-03-24 Aventis Behring GmbH Sterilisationsprozess für Proteine enthaltende biologische Zubereitungen
EP1415669A1 (de) * 2002-09-19 2004-05-06 Aventis Behring GmbH Sterilisationsverfahren für Protein enthaltende biologische Zusammensetzungen
AU2004216476B2 (en) 2003-02-27 2009-01-08 Takeda Pharmaceutical Company Limited Method for the validatable inactivation of pathogens in a biological fluid by irradiation
UA87836C2 (ru) 2004-02-27 2009-08-25 Октафарма Аг Способ получения очищенных, безопасных с вирусологической точки зрения препаратов антител
DE102005062410A1 (de) * 2005-12-23 2007-08-09 Forschungsgemeinschaft Der Drk-Blutspendedienste E.V. Verfahren zur Bestrahlung von Thrombozytenkonzentraten in flexiblen Behältnissen mit ultraviolettem Licht
DE102005062634A1 (de) 2005-12-23 2007-06-28 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Verfahren zur Inaktivierung von Pathogenen in Spenderblut, Blutplasma oder Erythrozytenkonzentraten in flexiblen Behältnissen unter Bewegung
US20090274576A1 (en) * 2006-01-18 2009-11-05 Barry Ressler System and method for container sterilization using UV light source
DE102006008125A1 (de) 2006-02-20 2007-09-06 Bayer Technology Services Gmbh Reinigbare Wendelmodule
EP1902740A1 (de) * 2006-09-19 2008-03-26 Maco Pharma S.A. Blutbeutelsystem und Verfahren, um Pathogene in Blutplättchenkonzentraten mit Hilfe des Blutbeutelsystems zu neutralisieren
EP2008669A1 (de) 2007-06-22 2008-12-31 Maco Pharma S.A. Bestrahlungsvorrichtung zur Deaktivierung von Krankheitserregern und/oder Leukozyten in einer biologischen Flüssigkeit und entsprechendes Verfahren
WO2009149020A1 (en) * 2008-06-04 2009-12-10 Triton Thalassic Technologies, Inc. Methods, systems and apparatus for monochromatic uv light sterilization
FR2941866B1 (fr) * 2009-02-09 2011-05-13 Maco Pharma Sa Procede pour modifier les proprietes d'un fluide par irradiation et systeme pour sa mise en oeuvre
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
CN104436171A (zh) * 2014-12-25 2015-03-25 华兰生物工程股份有限公司 一种制备人纤维蛋白原制剂的方法及其制备的制剂
KR101923569B1 (ko) * 2017-01-12 2018-11-29 비클시스템주식회사 유브이씨 엘이디를 이용한 광면역치료기
JP7157137B2 (ja) * 2017-08-11 2022-10-19 アクイセンス テクノロジーズ エルエルシー 照射のための装置および方法
CN111317841A (zh) * 2020-03-04 2020-06-23 上海朝惠环保科技有限公司 一种自动化消毒系统及消毒控制方法
EP4384143A1 (de) 2021-08-13 2024-06-19 Biotest AG Fibrinogenzusammensetzungen und verfahren zu ihrer herstellung
AT526979A1 (de) * 2023-02-28 2024-09-15 Sallinger Mst Eur Ing Peter Vorrichtung, Verfahren und Anordnung zur Behandlung des Abfallfluids einer hämatologischen Analysevorrichtung

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926556A (en) * 1973-05-30 1975-12-16 Raymond Marcel Gut Boucher Biocidal electromagnetic synergistic process
US3894236A (en) * 1973-12-10 1975-07-08 Wayne K Hazelrigg Device for irradiating fluids
DE2916711A1 (de) 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
GB8630102D0 (en) * 1986-12-17 1987-01-28 Gunn A Blood processing device
DE3734923C1 (de) 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
GB8807380D0 (en) * 1988-03-29 1988-05-05 Gunn A Blood processing apparatus
DE3824647A1 (de) * 1988-07-20 1990-02-01 Wedeco Entkeimungsanlagen Vorrichtung zur bestrahlung von medien mittels uv-licht
US5024766A (en) * 1988-11-09 1991-06-18 Shahzad Mahmud Point of use deionized water purification unit
DE4005488A1 (de) * 1990-02-21 1991-08-22 Wabner Dietrich Verfahren und vorrichtung zur wasserentgiftung
JP2968086B2 (ja) * 1990-08-28 1999-10-25 古野電気株式会社 水溶性切削油の嫌臭気除去装置
EP0653911B1 (de) * 1992-08-07 2000-05-17 Cerus Corporation Verfahren zur inaktivierung von bakterien in blutpräparaten mit hilfe von methoxypsoralen
JPH06279297A (ja) * 1993-03-25 1994-10-04 Asahi Chem Ind Co Ltd ウィルス感染性除去方法およびその装置
JP3426237B2 (ja) 1993-05-28 2003-07-14 ニューヨーク ブラッド センター，インコーポレイティド 生物学的組成物の滅菌方法及びこの方法によって生成される製剤
EP0707633A4 (de) * 1993-06-23 1996-08-14 New York Blood Center Inc System zur viralen inaktivierung von blut
JPH07196531A (ja) * 1993-12-28 1995-08-01 Chemo Sero Therapeut Res Inst 血液凝固因子の感染性夾雑ウイルス不活化法
EP0771324B2 (de) * 1994-07-14 2011-02-09 CAF-DCF Département Central de Fractionnement de la Croix Rouge S.C.R.L. Fibrinogenkonzentrate aus blutplasma, verfahren und anlage für ihre herstellung
ATE367830T1 (de) * 1995-07-14 2007-08-15 Caf Dcf Cvba Scrl Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten
GB9821342D0 (en) * 1998-10-02 1998-11-25 Common Services Agency Device for treatment of biological fluids
WO2006058062A2 (en) * 2004-11-22 2006-06-01 Energex Systems, Inc. Blood irradiation system, associated devices and methods for irradiating blood

Also Published As

Publication number Publication date
ES2290957T3 (es) 2008-02-16
EP0840624A1 (de) 1998-05-13
JP2009077707A (ja) 2009-04-16
DE29624488U1 (de) 2004-04-15
DE96923791T1 (de) 2004-07-08
US20010046450A1 (en) 2001-11-29
DE69637181T2 (de) 2008-04-17
DE69637181D1 (de) 2007-09-06
DK0840624T3 (da) 2007-11-05
EP1842561A1 (de) 2007-10-10
WO1997003706A1 (fr) 1997-02-06
CA2225470A1 (en) 1997-02-06
US6833108B2 (en) 2004-12-21
US6190608B1 (en) 2001-02-20
JPH11509210A (ja) 1999-08-17
EP0840624B1 (de) 2007-07-25
CA2225470C (en) 2010-06-29

Similar Documents

Publication Publication Date Title
ATE367830T1 (de) Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten
ATE220927T1 (de) Inaktivierung von prionen in bindegewebematerialen
DE69636674D1 (de) Vorrichtung zur wärmebehandlung von gewebe
DE3789158D1 (de) Verfahren zur Sterilisation und Vorrichtung dafür.
ATE73663T1 (de) Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten.
DE69621161D1 (de) Verfahren und zusammensetzungen zur selektiven modifikation von nukleinsaeuren
DE69525473D1 (de) Vorrichtung zur behandlung von blutgefässen
DE59600309D1 (de) Vorrichtung zur Behandlung von Flüssigkeiten, insbesondere von Blut
ATA304586A (de) Vorrichtung zur aufbereitung von wasser
DE69535758D1 (de) Lipid-analoge zur behandlung von viralen infektionen
ATA123791A (de) Verfahren zur herstellung eines inaktivierten blutproduktes
DE59003825D1 (de) Vorrichtung zur Erzeugung von Ozon.
DE69626976D1 (de) BEHANDLUNG EINER PROTEINLÖSUNG MIT A1/Fe UND ANSCHLIESENDE MEMBRANKONZENTRATION
DE69630321D1 (de) Vorrichtung zur örtlichen wärmebehandlung von gewebe
DE69129115D1 (de) Neues verfahren zur behandlung von depression
DE69421196D1 (de) Vorrichtung zur behandlung von überbiss
DE69521576D1 (de) Vorrichtung zur aeroben Behandlung von Abwasser
ATE204705T1 (de) Pflaster zur behandlung von pflanzen
DE69601242D1 (de) Vorrichtung zur Erzeugung von Ozon
ATE194648T1 (de) Verfahren zur inaktivierung von viren in präparationen von proteinen
ATE211928T1 (de) Verfahren zur inaktivierung von viren in proteinen
ATE285255T1 (de) Verfahren zur inaktivierung von viren
DE69105440D1 (de) Vorrichtung zur Erzeugung von mehreren Lichtstrahlen.
FI903143A0 (fi) Menetelmä ihmisen nuhaviruksen serotyypittämiseksi
DE58907891D1 (de) Verfahren zur Sterilisation von intraocularen Linsen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0840624

Country of ref document: EP